BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 319 filers reported holding BIONTECH SE in Q4 2022. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,788,633 | -37.4% | 44,078 | -37.8% | 0.00% | -33.3% |
Q2 2023 | $7,648,999 | -21.9% | 70,870 | -9.9% | 0.00% | -25.0% |
Q1 2023 | $9,793,818 | -1.2% | 78,621 | +19.1% | 0.00% | -20.0% |
Q4 2022 | $9,916,473 | +181.3% | 66,013 | +152.6% | 0.01% | +150.0% |
Q3 2022 | $3,525,000 | -77.7% | 26,135 | -75.4% | 0.00% | -71.4% |
Q2 2022 | $15,813,000 | -89.1% | 106,061 | -87.5% | 0.01% | -85.1% |
Q1 2022 | $145,085,000 | -50.1% | 850,640 | -24.6% | 0.05% | -50.5% |
Q4 2021 | $290,840,000 | -28.0% | 1,128,159 | -23.7% | 0.10% | -33.6% |
Q3 2021 | $403,697,000 | +160.7% | 1,478,798 | +113.8% | 0.14% | +138.3% |
Q2 2021 | $154,862,000 | +272.3% | 691,720 | +81.6% | 0.06% | +185.7% |
Q1 2021 | $41,592,000 | -41.5% | 380,909 | -56.3% | 0.02% | -40.0% |
Q4 2020 | $71,075,000 | +54.6% | 871,876 | +30.0% | 0.04% | +25.0% |
Q3 2020 | $45,981,000 | +392.7% | 670,590 | +381.2% | 0.03% | +366.7% |
Q2 2020 | $9,333,000 | +1105.8% | 139,363 | +951.9% | 0.01% | +500.0% |
Q1 2020 | $774,000 | – | 13,249 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 148,674 | $16,151,943 | 19.26% |
Quinn Opportunity Partners LLC | 659,383 | $71,635,369 | 9.22% |
Systrade AG | 50,000 | $5,432,000 | 4.70% |
Crocodile Capital Partners GmbH | 29,586 | $3,214,223 | 3.03% |
ALTRINSIC GLOBAL ADVISORS LLC | 700,421 | $76,093,737 | 2.94% |
Temasek Holdings (Private) Ltd | 4,518,080 | $490,844,211 | 2.92% |
PARUS FINANCE (UK) Ltd | 25,662 | $2,787,920 | 1.74% |
FLOSSBACH VON STORCH AG | 3,513,215 | $381,675,678 | 1.68% |
AtonRa Partners | 4,707 | $511,368 | 1.07% |
Baader Bank Aktiengesellschaft | 135,093 | $14,617,456 | 0.99% |